Rakkiyappan Chandran

Dr. Rakkiyappan Chandran

Nanoscience, University of North Carolina at Greensboro, Greensboro, North Carolina, USA
Principal Scientist

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2013 in FEMS Microbiology Reviews
Verified
Journal Article
Open access
PDF file
FVFatma Vatansever
Fatma Vatansever
WMWanessa C.M.A. de Melo
Wanessa C.M.A. de Melo
PAPinar Avci
Pinar Avci
DVDaniela Vecchio
Daniela Vecchio
MSMagesh Sadasivam
Magesh Sadasivam
Michael R. HamblinMichael R. Hamblin
Michael R. Hamblin
Reactive oxygen species are involved in cell signaling and disease causing damages and in the antimicrobial arena-mediated killing via bactericidal antibiotics,

1 July 2013 in Expert Review of Anti-infective Therapy
Verified
Journal Article
Closed access
WMWanessa Cma de Melo
Wanessa Cma de Melo
PAPinar Avci
Pinar Avci
MOMilene Nóbrega de Oliveira
Milene Nóbrega de Oliveira
AGAsheesh Gupta
Asheesh Gupta
DVDaniela Vecchio
Daniela Vecchio
Michael R. HamblinMichael R. Hamblin
Michael R. Hamblin
Microbial biofilms are responsible for a variety of microbial infections in different parts of the body, such as urinary tract infections, catheter infections, middle-ear infections, gingivitis, ca...

1 May 2014 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
SLShanmugamurthy Lakshmanan
Shanmugamurthy Lakshmanan
GGGaurav K. Gupta
Gaurav K. Gupta
PAPinar Avci
Pinar Avci
Rakkiyappan ChandranRakkiyappan Chandran
Rakkiyappan Chandran
MSMagesh Sadasivam
Magesh Sadasivam
Michael R. HamblinMichael R. Hamblin
Michael R. Hamblin

8 January 2013 in Expert Opinion on Drug Discovery
Verified
Journal Article
Closed access
PAPinar Avci
Pinar Avci
MSMagesh Sadasivam
Magesh Sadasivam
AGAsheesh Gupta
Asheesh Gupta
WMWanessa Cma De Melo
Wanessa Cma De Melo
YHYing-Ying Huang
Ying-Ying Huang
Michael R. HamblinMichael R. Hamblin
Michael R. Hamblin
Introduction: Discovery of novel drugs, treatments, and testing of consumer products in the field of dermatology is a multi-billion dollar business. Due to the distressing nature of many dermatolog...

1 September 2013 in Biotechnology Advances
Verified
Journal Article
Closed access
AGAsheesh Gupta
Asheesh Gupta
PAPinar Avci
Pinar Avci
MSMagesh Sadasivam
Magesh Sadasivam
Rakkiyappan ChandranRakkiyappan Chandran
Rakkiyappan Chandran
NPNivaldo Antonio Parizotto
Nivaldo Antonio Parizotto
Michael R. HamblinMichael R. Hamblin
Michael R. Hamblin

1 March 2016 in Micron
Verified
Journal Article
Closed access
Rakkiyappan ChandranRakkiyappan Chandran
Rakkiyappan Chandran
LWLee Williams
Lee Williams
AHAlbert Hung
Albert Hung
KNKyle Nowlin
Kyle Nowlin
DLDennis LaJeunesse
Dennis LaJeunesse